NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Portal Biotechnologies

Portal Biotechnologies

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://portal.bio/

Last Round

Early Funding

May 29, 2026

Total Funding Raised

$12M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Portal Biotechnologies is a biotechnology company that provides a cell engineering platform focused on intracellular delivery to accelerate advances enabled by RNA, gene editing, and AI-driven technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware + Subscription

AI Layer

Non-AI

Keywords

intracellular deliverycell engineeringmechanoporationcell therapy productionbiotech hardwarehigh-throughput screeningsynthetic biologydrug discoverylab automationbenchtop biomanufacturingcell transfectionbiotech toolsDARPA

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Portal Biotechnologies Comps

Public and private peers based on sector, stage, and business model.

Portal Biotechnologies comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Portal Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 29, 2026
SeedDec 19, 2024
Pre SeedMar 19, 2024

Key People

Founding team and executive leadership

Armon Sharei

Founder And CEO

Founding Team

Alec Barclay

Chief Operating Officer

Executive Team

Portal Biotechnologies Investors

Notable investors and investment history

Portal Biotechnologies investors
InvestorRounds
TechU VenturesEarly Funding
NFXEarly Funding
10X CapitalPre Seed
Pear VCEarly Funding, Seed, Pre Seed
IA VenturesEarly Funding, Seed
Conscience VCPre Seed
Undeterred CapitalEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 29, 2026

    $12M raised in Seed Round.

  • Jan 20, 2026

    Developing predictive frameworks for vaccines and immunotherapies.

Portal Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Portal Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Portal Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Employee Range77
Year Founded2023
Last FundingMay 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.